SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Systematic reviews and cancer research: a suggested stepwise approach
16 references·0 citing·16 second hop
Systematic reviews and cancer research: a suggested stepwise approach (2018)Systematic reviews and cancer research: a…Basics of meta‐analysis: I 2 is not an absolute measure of heterogeneity (2017)Basics of meta‐analysis: I 2 …The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations (2015)The PRISMA Extension Statemen…Summarizing systematic reviews (2015)Summarizing systematic reviewsROBIS: A new tool to assess risk of bias in systematic reviews was developed (2015)ROBIS: A new tool to assess r…Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation (2015)Preferred reporting items for…Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement (2015)Preferred reporting items for…Preferred Reporting Items for a Systematic Review and Meta-analysis of Individual Participant Data (2015)Preferred Reporting Items for…GRADE guidelines: 3. Rating the quality of evidence (2011)GRADE guidelines: 3. Rating t…The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration (2009)The PRISMA Statement for Repo…The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration (2009)The PRISMA statement for repo…Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. (2009)Preferred reporting items for…Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement (2009)Preferred Reporting Items for…Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement (2009)Preferred reporting items for…Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement (2009)Preferred Reporting Items for…A Re-Evaluation of Random-Effects Meta-Analysis (2008)A Re-Evaluation of Random-Eff…Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews (2007)Development of AMSTAR: a meas…Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration (2007)The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration (2009)Rayyan—a web and mobile app for systematic reviews (2016)The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies (2007)The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration (2009)PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation (2018)Measuring inconsistency in meta-analyses (2003)Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement (1999)The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration (2001)The PRISMA 2020 statement: an updated guideline for reporting systematic reviews (2021)The PRISMA 2020 statement: an updated guideline for reporting systematic reviews (2021)The PRISMA 2020 statement: An updated guideline for reporting systematic reviews (2021)GRADE guidelines: 7. Rating the quality of evidence—inconsistency (2011)A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis (2014)PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews (2021)The Measurement of Observer Agreement for Categorical Data (1977)
this work references cited by second hop

References

  • 2009Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement83,813 cited
  • 2009Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement63,979 cited
  • 2009Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.44,857 cited
  • 2009Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement37,549 cited
  • 2009The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration28,094 cited
  • 2015Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement26,189 cited
  • 2015Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation13,108 cited
  • 2009The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration10,571 cited
  • 2011GRADE guidelines: 3. Rating the quality of evidence8,270 cited
  • 2015The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations8,248 cited
  • 2007Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews4,376 cited
  • 2015Summarizing systematic reviews2,581 cited
  • 2008A Re-Evaluation of Random-Effects Meta-Analysis

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

2,562 cited
  • 2015ROBIS: A new tool to assess risk of bias in systematic reviews was developed2,266 cited
  • 2015Preferred Reporting Items for a Systematic Review and Meta-analysis of Individual Participant Data2,123 cited
  • 2017Basics of meta‐analysis: I 2 is not an absolute measure of heterogeneity1,841 cited
  • Cited by

    No citing works inside the corpus for this window.